共 37 条
[1]
Avorn J., Medication use in older patients: better policy could encourage better practice, JAMA, 304, 14, pp. 1606-1607, (2010)
[2]
Sumukadas D., McMurdo M.E., Mangoni A.A., Guthrie B., Temporal trends in anticholinergic medication prescription in older people: repeated cross-sectional analysis of population prescribing data, Age Ageing, 43, 4, pp. 515-521, (2014)
[3]
Hovstadius B., Hovstadius K., Astrand B., Petersson G., Increasing polypharmacy-an individual-based study of the Swedish population 2005-2008, BMC Clin. Pharmacol., 10, (2010)
[4]
Payne R.A., Avery A.J., Polypharmacy: one of the greatest prescribing challenges in general practice, Br. J. Gen. Pract., 61, 583, pp. 83-84, (2011)
[5]
Polypharmacy and medicines optimisation: making it safe and sound, (2013)
[6]
Cahir C., Fahey T., Teeling M., Teljeur C., Feely J., Bennett K., Potentially inappropriate prescribing and cost outcomes for older people: a national population study, Br. J. Clin. Pharmacol., 69, 5, pp. 543-552, (2010)
[7]
Bradley M.C., Fahey T., Cahir C., Bennett K., O'Reilly D., Parsons C., Hughes C.M., Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database, Eur. J. Clin. Pharmacol., 68, 10, pp. 1425-1433, (2012)
[8]
Maher R.L., Hanlon J., Hajjar E.R., Clinical consequences of polypharmacy in elderly, Expert Opin. Drug Saf, 13, 1, pp. 57-65, (2014)
[9]
Barnett K., Mercer S.W., Norbury M., Watt G., Wyke S., Guthrie B., Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study, Lancet, 380, 9836, pp. 37-43, (2012)
[10]
Hughes L.D., McMurdo M.E., Guthrie B., Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity, Age Ageing, 42, 1, pp. 62-69, (2013)